|
End-of-day quote
New Zealand S.E.
2026-09-29
|
5-day change | 1st Jan Change | ||
| 4.340 NZD | -0.23% |
|
+2.84% | +28.40% |
| 09-08 | Aft Pharmaceuticals Limited Partners with Mark Cuban Cost Plus Drug Company to Bring Combogesic to the U.S | CI |
| 07-31 | AFT Pharmaceuticals Limited - Shareholder/Analyst Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.23% | +2.84% | -3.56% | +17.30% | +28.40% | +53.90% | +26.16% | +5.34% | +40.45% | 256M | ||
| -0.01% | +1.24% | +0.85% | -3.68% | +10.23% | +63.06% | +120.55% | +414.25% | +1,385.62% | 1,056B | ||
| -1.61% | -0.60% | -0.18% | +3.50% | +29.29% | +47.32% | +71.79% | +63.13% | +128.17% | 645B | ||
| -1.12% | -0.72% | +3.06% | +3.53% | +15.23% | +17.98% | +76.63% | +141.91% | +319.12% | 465B | ||
| +0.53% | -3.28% | -0.43% | +5.56% | +7.04% | +35.17% | +41.62% | +2.73% | +45.77% | 335B | ||
| +0.76% | +3.64% | -1.12% | -3.71% | +11.20% | +21.73% | +30.53% | +58.64% | +59.53% | 275B | ||
| -0.09% | +0.03% | +3.95% | -11.82% | -9.83% | +11.20% | +13.55% | +38.80% | +148.48% | 255B | ||
| +1.32% | +3.27% | -2.03% | +17.50% | +29.43% | +54.63% | +57.63% | +97.13% | +156.05% | 229B | ||
| -0.61% | -0.91% | +3.84% | +19.75% | +23.25% | +34.33% | +101.87% | +113.25% | +94.30% | 188B | ||
| -0.49% | -0.59% | -14.24% | -20.30% | -22.91% | -27.25% | -60.62% | -19.30% | +82.10% | 169B | ||
| 0.00% | +2.83% | +2.72% | +17.85% | +15.34% | +20.42% | -13.42% | -34.02% | -13.81% | 164B | ||
| -0.18% | +2.28% | -2.76% | +5.42% | +16.18% | +33.24% | +51.47% | +189.06% | +519.68% | 134B | ||
| -1.60% | +0.98% | -5.59% | +7.34% | +16.54% | +42.38% | +8.30% | +3.70% | +16.69% | 128B | ||
| +0.38% | -1.11% | -0.35% | -5.86% | +2.22% | +18.45% | +25.67% | +6.30% | -9.19% | 98.21B | ||
| +0.38% | -1.87% | -6.60% | -4.45% | -13.27% | -8.67% | -29.54% | -13.65% | +6.06% | 97.03B | ||
| +2.12% | -6.39% | -9.95% | -17.37% | -24.48% | -3.46% | +37.30% | +51.72% | +413.76% | 63.61B | ||
| +0.71% | -1.78% | +0.26% | +12.12% | +19.54% | +33.95% | +26.31% | +56.26% | +19.84% | 58.12B | ||
| +1.11% | -0.04% | +0.51% | +1.82% | +33.18% | +74.60% | +9.86% | +4.86% | -44.88% | 54.41B | ||
| +2.39% | +0.73% | +7.59% | +31.21% | +39.15% | +98.95% | +291.06% | +305.40% | -22.03% | 46.39B | ||
| +2.59% | -0.22% | -3.59% | -13.81% | -23.42% | -34.08% | +1.51% | -8.61% | +180.13% | 44.75B | ||
| Average | +0.40% | -0.71% | -1.38% | +3.10% | +10.12% | +29.39% | +44.41% | +73.84% | +176.29% | 225.23B | |
| Weighted average by Cap. | +0.22% | +0.08% | -0.24% | +1.39% | +12.17% | +36.30% | +62.28% | +144.60% | +428.91% |
- Stock Market
- Stocks
- AFT Stock
- Sector AFT Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















